EVOTEC SE (EVOTF) Stock Price, News & Analysis
What Changed
Price Move History
- Daily moves over 5%
- 5 7 sessions, September 16, 2025 to October 5, 2026
- Largest daily move
- -50.3% close of October 5, 2026
- 1-year change
- -54.3% closing prices, September 16, 2025 to October 5, 2026
Company Description
EVOTEC SE (OTC: EVOTF) is classified in the drug manufacturers - specialty & generic industry within the Healthcare sector and carries a market capitalization of $590.8M.
EVOTF has declined 54.3% over the past year. The last closing price was $3.33.
For FY2024, EVOTEC SE reported revenue of $824.9M with net income of -$203.0M and diluted earnings per share of -$1.15. The company operates at a net profit margin of -24.6%.
This page collects what Stock Titan holds for EVOTF, including price data, latest news, SEC filings, financial highlights, and short interest trends.
Stock Performance
EVOTEC SE (EVOTF) closed at $3.33 on October 5, 2026. Over the past 12 months, the price has lost 54.3%.
EVOTF Metrics & Rankings
Price returns through October 5, 2026. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
EVOTEC SE has 7 recent news articles. Of the recent coverage, 0 articles coincided with positive price movement and 1 with negative movement. Key topics include partnership, earnings, covid-19. View all EVOTF news →
SEC Filings
EVOTEC SE has filed 10 recent SEC filings, including 8 Form 6-K, 2 Form SCHEDULE 13D/A. The most recent filing was submitted on October 15, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all EVOTF SEC filings →
Financial Highlights
EVOTEC SE generated $824.9M in revenue in FY2024, retaining a 14.4% gross margin, operating income reached -$147.5M (-17.9% operating margin), and net income was -$203.0M, reflecting a -24.6% net profit margin. Diluted earnings per share stood at -$1.15. The company generated $18.9M in operating cash flow. The current ratio was 1.98, measuring current assets divided by current liabilities.
Upcoming Events
Short Interest History
Short interest in EVOTEC SE (EVOTF) currently stands at 2.8 million shares, up 8.5% from the previous reporting period, representing 1.8% of the float. Since October 2025, short interest has increased by 265.0%.
Days to Cover History
Days to cover for EVOTEC SE (EVOTF) currently stands at 51.5 days, down 94.9% from the previous period. The ratio is the reported short interest divided by the average daily trading volume. Since October 2025, the figure has decreased by 94.2%. Across the settlements charted above, it has ranged from 51.5 to 1000.0 days.
EVOTF Company Profile & Sector Positioning
EVOTEC SE (EVOTF) operates in the Drug Manufacturers - Specialty & Generic industry within the broader Healthcare sector and is listed on the OTC.
Investors comparing EVOTF often look at related companies in the same sector, including TRULIEVE CANNABIS CORP (TCNNF), NIKA PHARMACEUTICALS INC (NIKA), ENDO INC (NDOI), GREEN THUMB INDUS SUB VTG (GTBIF), and ELITE PHARMS INC (ELTP). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate EVOTF's relative position within its industry.